Sarepta therapeutics has announced preliminary results of a gene therapy trial that is using a harmless virus to deliver a small but functional …
Sarepta announce early, preliminary gene therapy trial resultsRead More

20 June 2018 by abzali123
Sarepta therapeutics has announced preliminary results of a gene therapy trial that is using a harmless virus to deliver a small but functional …
Sarepta announce early, preliminary gene therapy trial resultsRead More

18 June 2018 by abzali123
DMD Pathfinders have worked with global health professionals to create a guide which provides information on nutrition for adults with Duchenne. They …
DMD Pathfinders launch new nutrition guide for adultsRead More

18 June 2018 by abzali123
Solid Biosciences have announced that the FDA has given approval for the company to restart the phase I/II IGNITE DMD clinical trial. The clinical …
Solid Biosciences announce FDA have removed clinical hold from their gene therapy trialRead More

11 June 2018 by abzali123
Thank you to the wonderful Abbie Smith and Michelle McDermott of Career Legal for organising the fantastic Bake Off on Friday 8 June for Action …

8 June 2018 by abzali123
Researchers from Queen Mary University of London have developed new cell-based technologies which could improve understanding of the muscle-wasting …
New technology could highlight potential treatments for Duchenne muscular dystrophyRead More

6 June 2018 by abzali123
Bone Protective Therapy in Duchenne MD Date: 2018-06-03 Number: 236 City: Hoofddorp, The Netherlands Description: 236th ENMC …
Action Duchenne represent our community at bone protective therapy ENMC workshopRead More

5 June 2018 by abzali123
SuAzio are currently conducting a study and are looking for individuals who live with Duchenne, or their caregivers to be part of this study. …

4 June 2018 by abzali123
- European Commission ratification anticipated in coming months - - Approval of the Translarna annual re-assessment also recommended by CHMP - PTC …

1 June 2018 by abzali123
Sarepta will seek re-examination of the opinion and request that a Scientific Advisory Group (SAG) be convened Sarepta have announced that the …

29 May 2018 by abzali123
Daiichi Sankyo have announced the top-line results of the Phase 1/2 clinical trial in Japan of DS-5141), which Daiichi Sankyo is jointly …
Daiichi Sankyo announces Phase 1/2 clinical trial resultsRead More

24 May 2018 by abzali123
96 amazing golfers and a further 34 evening guests gathered to support the wonderful Shippey family at their second annual Cure4George charity golf …
Support for the Shippey family at their annual Golf DayRead More

23 May 2018 by abzali123
Muscular Dystrophy News Today have reported that Sarepta Therapeutics and Invitae, a company specialising in genetic diagnostics, are …
Sarepta collaborate with Invitae to speed up diagnosis of DuchenneRead More
Action Duchenne
2nd Floor
South
One Castle Park
Tower Hill
Bristol
BS2 OJA
0300 102 1762
info@actionduchenne.org
